Segments - Neovaginal Surgery Market by Product (Laparoscopic Neovaginal Surgeries Kits, Vaginal Stents, and Vaginal Dilators), Treatment Type (Vaginal Atresia Treatment [Vecchietti Technique and McIndoe Technique], Vaginal Agenesis Treatment, and Sex Reassignment Surgery), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The Global Neovaginal Surgery Market Size was valued at USD 1.13 Billion in 2022 and is likely to reach USD 1.55 Billion by 2031, expanding at a CAGR of 3.61% during the forecast period, 2023–2031. The growth of the market is attributed to an increase in the number of gender verification surgeries and the availability of insurance.
Rising prevalence of vaginal agenesis and other congenital anomalies is driving the neovaginal surgery market. Vaginal agenesis is a condition where the vagina fails to develop properly during fetal development. This condition affects female births. Neovaginal surgery is often used to create a functional vagina in these cases. For instance,
Increased awareness and acceptance of gender reassignment surgery are propelling the neovaginal surgery market. Rising acceptance of gender diversity in society is boosting the demand for gender reassignment surgery. Neovaginal surgery is a common procedure for transgender women who wish to undergo gender confirmation surgery.
The research report finds that the COVID-19 pandemic affected the demand and supply in the neovaginal surgery market. Lockdowns across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production, leading to an unfortunate decline in market growth. The launch of vaccines to combat the COVID-19 pandemic is expected to contribute to the market growth over the forecast period.
Artificial intelligence is used to provide real-time guidance during surgery, helping surgeons identify critical structures and avoid damaging them. This reduces the risk of complications and improves surgical outcomes. It is used to analyze large amounts of data from patient records, surgical outcomes, and research studies. This helps to identify trends, improve understanding of the factors that affect surgical outcomes, and guide future research.
Advancements in surgical techniques and technologies are fueling the market. The development of surgical techniques and technologies has made neovaginal surgery safe, effective, and less invasive. This has led to increased patient satisfaction and high demand for these procedures. For instance,
Improved access to healthcare services and insurance coverage for these procedures is propelling the market. Many people are able to access neovaginal surgery, as healthcare access improves and insurance coverage expands. Insurance coverage for gender confirmation surgeries, including neovaginal surgery, has been expanding. Many insurance companies now recognize the medical necessity of these procedures and provide coverage for eligible individuals.
Growing demand for cosmetic genital surgery is expected to boost the market. The trend of cosmetic genital surgery is growing. It includes procedures such as labiaplasty and vaginoplasty. Neovaginal surgery is often performed as part of these procedures for an aesthetically pleasing appearance.
The high cost of the procedure is estimated to restrict the market growth during the forecast period. Neovaginal surgery is expensive, and the cost is not covered by insurance in all cases. This limits access to the procedure for individuals who cannot afford the out-of-pocket expenses. Neovaginal surgery carries risks and potential complications. These include infection, bleeding, scarring, and complications related to anesthesia. The potential for these risks is expected to deter some individuals from undergoing the procedure.
Technological advancements in surgical techniques and instruments are expected to create lucrative opportunities in the market. This includes the development of minimally invasive approaches, robotic-assisted surgery, and tissue engineering techniques, which further improve the outcomes of neovaginal surgeries.
Neovaginal surgeries are not limited to a specific region and have a global market potential. Improving access to healthcare in various parts of the world is expected to boost the demand for these procedures, providing opportunities for market expansion.
The report on the global neovaginal surgery market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Neovaginal Surgery Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Product (Laparoscopic Neovaginal Surgeries Kits, Vaginal Stents, and Vaginal Dilators), and Treatment Type (Vaginal Atresia Treatment [Vecchietti Technique and McIndoe Technique], Vaginal Agenesis Treatment, and Sex Reassignment Surgery) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
Chettawut Plastic Surgery Center; González-Fontana; Icahn School of Medicine at Mount Sinai; KESSEL Medintim GmbH; Owen Mumford Ltd.; Phuket Plastic Surgery Institute (PPSI); and Vuvatech. |
Based on product, the neovaginal surgery market is segregated into laparoscopic neovaginal surgery kits, vaginal stents, and vaginal dilators. The laparoscopic neovaginal surgeries kits segment held more than 50% of the total market share in 2020, owing to the growing demand for minimally invasive procedures for curing vaginal agenesis in female patients and the increasing frequency of laparoscopic surgeries performed globally. For instance,
The American Society of Plastic Surgeons reported that labiaplasty, a procedure often performed in conjunction with neovaginal surgery, registered a 39% increase in the number of procedures performed between 2015 and 2020.
The increased number of laparoscopic procedures conducted globally, owing to a growing demand for minimally invasive surgeries for curing vaginal agenesis, is propelling the laparoscopic neovaginal surgeries kits segment. The vaginal dilators segment is estimated to grow at a rapid pace during the forecast period.
Vaginal dilators help to repair or extend the vaginal opening's musculature and tissues. An increase in the use of vaginal dilators for neovaginal construction is anticipated to drive the segment. Furthermore, silicon dilators are becoming popular among women with Mayer–Rokitansky–Küster–Hauser syndrome (MRKH).
Based on treatment type, the market is fragmented into vaginal atresia treatment, vaginal agenesis treatment, and sex reassignment surgery (SRS). The vaginal atresia treatment segment is further bifurcated into Vecchietti technique and McIndoe technique. The sex reassignment surgery segment held more than 50% of the total revenue share in 2020 and is projected to dominate the market during the forecast period.
The growth of the segment is attributed to the increasing demand for sex change surgeries worldwide, such as male-to-female sex conversion. Gender reassignment surgeries were included in the insurance policy, due to the rising demand for these procedures in recent years. For instance,
According to a report published by the American Society of Plastic Surgeons on September 26, 2023, USD 26.2 million surgical and minimally invasive cosmetic and reconstructive procedures were performed in the US in 2022. A 19% increase in cosmetic surgery procedures has been registered since 2019.
SRS is now included in the health insurance plans of several countries. In agenesis patients, several surgical techniques such as sigmoid vaginoplasty and Davydov operation are used to create neovagina.
In terms of region, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Europe holds a major share of the market, owing to the rising demand for vaginoplasty, encouraging government laws & regulations for these treatments, and efforts to raise awareness about cosmetic surgery and its risks.
The number of surgical treatments and techniques is continuously increasing, as social knowledge and acceptance of gender reassignment grows in Europe, which is driving the market in the region.
The market in Asia Pacific is projected to expand at a high CAGR during the forecast period. Growth of the market is attributed to the increased awareness of neovaginal surgery and an increase in the number of medical tourists visiting the region, due to low healthcare costs.
Key players competing in the neovaginal surgery market include Chettawut Plastic Surgery Center; González-Fontana; Icahn School of Medicine at Mount Sinai; KESSEL Medintim GmbH; Owen Mumford Ltd.; Phuket Plastic Surgery Institute (PPSI); and Vuvatech.
Some of these players are using several market strategies, such as acquisitions, mergers, collaborations, partnerships, capacity expansion, and product launches, to enhance their market share to generate revenue and raise their production in the coming years. For instance,
The sex reassignment surgery segment holds the major share of the market.
The global neovaginal surgery market size was valued at USD 1.13 Billion in 2022 and is likely to reach USD 1.55 Billion by 2031.
Key players competing in the neovaginal surgery market include Chettawut Plastic Surgery Center; González-Fontana; Icahn School of Medicine at Mount Sinai; KESSEL Medintim GmbH; Owen Mumford Ltd.; Phuket Plastic Surgery Institute (PPSI); and Vuvatech.
Europe holds the largest share of the market.